Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound
Daniel Coluccia(Brain Tumour Research), James T. Rutka(Hospital for Sick Children), Megan Wu(Brain Tumour Research), Meaghan A. O’Reilly(Sunnybrook Health Science Centre), Christian A. Smith(Hampton University), Sunit Das(University Health Network), Amanda Luck(Brain Tumour Research), Kullervo Hynynen(University of Toronto), Alexandra N. Riemenschneider(Brain Tumour Research), Roberto J. Diaz(Montreal Neurological Institute and Hospital), Cameron Ackerley(University of Toronto), Carlyn A. Figueiredo(Hospital for Sick Children)
Cited by 136
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications
|NeuroImage|2004|685
Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruption
|Proceedings of the National Academy of Sciences|2006|648
MR Imaging-guided Focused Ultrasound Surgery of Fibroadenomas in the Breast: A Feasibility Study
|Radiology|2001|636
Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles
|Ultrasound in Medicine & Biology|2004|619